SA
Sanjivani Paranteral Limited.
SANJIVIN.BO · BSE
₹190.00 +0.00% (+₹0.00)
1M -3.59%
Market Cap ₹2.37B
P/E Ratio 32.42x
Div. Yield -
ROE 17.95%
Bulios Fair Price
₹248.55
30.8% upside
Current Price
₹190
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SANJIVIN.BO is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
36 /100
Fair EV/EBITDA 19.85x
P/S 3.18x
P/B 4.91x
Growth
84 /100
Growing Rev. growth 32.15%
EPS growth 11.15%
Book val. growth N/A
Profitability
55 /100
Moderate Net margin 9.80%
Op. margin 13.57%
FCF margin 7.91%
Quality
71 /100
Excellent ROE 17.95%
ROA 8.31%
Asset turnover 0.85x
Debt
90 /100
Low Current ratio 1.38x
Int. coverage 11.84x
Net debt/EBITDA 1.03x
Stability
72 /100
Stable Rev. volatility 18.28%
EPS volatility 17.13%
Profitable years 5
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SANJIVIN.BO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Ashwani Anamisharan Khemka
Employees
43
Headquarters
Mumbai